Verus Capital Partners »

Exagen shares owned by Verus Capital Partners

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Verus Capital Partners from 13F filings

Historical chart of Verus Capital Partners investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Verus Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Verus Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $39k 13k 3.09

More positions owned by Verus Capital Partners

Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Scp Etf (IJR)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Actively Managed Exc Total Return (GTO)
Ishares Tr Msci Intl Qualty (IQLT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Total Usd (IUSB)

View all positions for Verus Capital Partners

Top funds holding Exagen

Cowen And Company
Silvercrest Asset Management Group
Stonepine Capital Management
Vanguard Group
Daniel D. Thurber
Morgan Stanley
Perkins Capital Management
Renaissance Technologies
Geode Capital Management
Kennedy Capital Management
Palumbo Wealth Management
Penbrook Managment
Nantahala Capital Management
BlackRock
Creative Planning

View all funds holding Exagen